USFDA gives nod to Granules India for Prazosin HCL capsules

Prazosin Hydrochloride capsules used for the treatment of high blood pressure

77
USFDA
Picture: Pixabay

Last Updated on December 30, 2021 by The Health Master

Granules India today said it has received approval from the US health regulator for its generic Prazosin Hydrochloride capsules used for the treatment of high blood pressure.

The US Food and Drug Administration (USFDA) granted approval to the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc. (GPI).

This is a wholly-owned foreign subsidiary of the company — for Prazosin Hydrochloride capsules, of strengths 1mg, 2mg and 5mg, Granules India said in a statement.

These capsules are bioequivalent to the reference listed drug product, Mini Plus Capsules 1mg, 2mg, and 5mg of Pfizer Inc, it said, adding the product would be available for the US market shortly.

Citing IQVIA/IMS Health data, the company said the current annual US market for Prazosin Hydrochloride 1mg, 2mg, and 5mg strengths is approximately $54 million.

USFDA gives nod to Lupin for this drug to treat Kidney disease

USFDA gives nod to Lupin generic Azilsartan Medoxomil tablets

USFDA authorises first oral antiviral to treat COVID

USFDA approves expanded use of Amgen’s psoriasis drug

USFDA gives nod to Cipla for Lanreotide injection

USFDA gives Orphan Drug Designation to Zydus for malaria treatment

E-pharmacies, Telemedicine to help cut health expenses

Won’t allow drug peddlers to ruin lives of youth: HM

What is ‘Delmicron’ ? Is it a cause of concern?

Hospital fined Rs 50,000 over waste disposal

Side-Effect of Ibuprofen – Painful Skin Disorders: India to act soon

CDSCO panel weighing risks and benefits of Covid drug Molnupiravir

5 reasons why e-Rx (electronic prescription) is better than paper Rx

Schedule for 19 FDCs permitted pre-1988 to give online presentation

Drug alert: 22 out of 1102 samples declared as NSQ in…

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner